Mechanisms of action of SGLT2 inhibitors and their beneficial effects on the cardiorenal axis.
Can J Physiol Pharmacol
; 100(2): 93-106, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-35112597
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cardiotonic Agents
/
Diabetes Mellitus, Type 2
/
Sodium-Glucose Transporter 2 Inhibitors
/
Heart Failure
Limits:
Humans
Language:
En
Journal:
Can J Physiol Pharmacol
Year:
2022
Document type:
Article
Affiliation country:
Italy
Country of publication:
Canada